Wednesday August 12, 2020

Ireland’s EU drug-buying partnership secures first deal

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
15th July, 2018

The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.

Spinraza is already being funded by the HSE in Ireland.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Irish doctors will not use the term ‘fully reversible’ in future, following a change in Britain’s NHS guidance on hormone treatment for transgender children

Aaron Rogan | 3 days ago

The founder of the expert group EndCoronavirus says New Zealand’s zero tolerance model is the only option against the virus

Rachel Lavin | 3 days ago

Unicef adviser says ‘special effort’ must be made to catch children up on immunisations missed due to Covid-19

Rachel Lavin | 3 days ago